-
Dacomitinib (PF-00299804) Assay Guide
2026-09-13
A scenario-based guide to using Dacomitinib (PF-00299804), SKU A8319, in viability, proliferation, cytotoxicity, and exploratory ferroptosis studies. It connects reported pan-HER potency with practical controls, formulation handling, interpretation limits, and vendor-selection considerations.
-
Tianhuang Formula, RAGE/POMC, and Berberine
2026-09-12
A 2026 pre-proof study identifies RAGE as a central nervous system target of berberine within Tianhuang Formula and links RAGE/POMC signaling to hypothalamic neuronal apoptosis, autophagy, and glucolipid regulation. Its integrated computational, cellular, and mouse-model design offers a mechanistic framework for metabolic research, although causal validation, dosing, and clinical translation remain unresolved.
-
Halazone and Sodium Current Inactivation in Frog Nerve
2026-09-12
The reference study used voltage-clamped frog nerve fibers to compare Halazone with chemically distinct oxidants and residue-reactive reagents. Its central finding was that Halazone and hypochlorous acid strongly reduced sodium-current inactivation, challenging a simple methionine-centered explanation and implicating membrane-lipid modification as a plausible alternative.
-
Halazone: From Water Disinfection to Ion-Channel Insight
2026-09-11
Halazone is more than a conventional water disinfection agent: its HOCl-generating chemistry supports rapid bactericidal action, while electrophysiology findings reveal a distinct route to sodium-channel modulation. This thought-leadership analysis translates those mechanisms into practical guidance for antimicrobial resistance research, neurophysiology, and translational assay design.
-
Reserpine N1867: Practical Lab QC Guide
2026-09-11
Reserpine (SKU N1867) provides a characterized research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide covers identity checks, DMSO preparation, storage, and failure prevention; it is not intended to support diagnostic, therapeutic, or medical use.
-
Tamsulosin Workflows for Urological Research
2026-09-10
Build reproducible Tamsulosin assays for α1A-linked smooth muscle relaxation, ureteral stone passage, and postoperative urinary retention models. This guide translates meta-analytic evidence into practical concentration, handling, endpoint, and troubleshooting decisions for translational laboratories.
-
USP42, JNK/p38 Signaling, and Breast Cancer Apoptosis
2026-09-10
The reference study identifies USP42 as a pro-tumorigenic deubiquitinating enzyme that supports breast cancer cell survival by suppressing JNK/p38-associated apoptosis. Its integrated cell-based, pathway-inhibitor, and xenograft experiments provide a preclinical framework for evaluating USP42 as a potential therapeutic target while highlighting important limits in mechanistic and clinical validation.
-
Magnetic Stimulation Targets GABRE in Schizophrenia
2026-09-09
This Molecular Psychiatry study identifies the GABAA receptor ε subunit, encoded by Gabre, in the left prelimbic cortex as a mechanistically actionable target for schizophrenia-like behaviors in mice. By combining focal magnetic stimulation with loss- and gain-of-function experiments, the authors connect GABRE regulation to synaptic abnormalities and suggest a p62/SQSTM1–GABARAP pathway that may support therapeutic modulation.
-
MLKL–Lysosome Crosstalk in Necroptosis
2026-09-09
The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a critical execution step in necroptosis. Its imaging, pharmacological, and genetic evidence places lysosomal cathepsin B release upstream of lethal cellular damage and provides a framework for testing lysosomal protease dependence in regulated cell death.
-
Nintedanib (BIBF 1120) in Precision Oncology
2026-09-08
Nintedanib (BIBF 1120) combines VEGFR, FGFR, and PDGFR blockade in one research tool for modeling angiogenesis, tumor signaling, and fibrosis. This guide translates its target profile into ATRX-aware glioma assays, practical dosing workflows, and troubleshooting strategies.
-
LKB1, Histone Lactylation, and Senescence in Lung Cancer
2026-09-07
The reference study identifies a mechanistic link between LKB1 loss, telomerase activation, and lung adenocarcinoma senescence through Sp1-dependent TERT transcription and histone lactylation. Its findings support combining telomerase inhibition with glycolysis-directed treatment, while also highlighting the need to validate this pathway across genetically diverse tumor models.
-
MPC, Lactate, and Dendritic Cells in CRC Immunity
2026-09-07
The 2025 reference study identifies mitochondrial pyruvate carrier loss as a metabolic driver of lactate accumulation, histone lactylation, dendritic-cell dysfunction, and weaker CD8+ T-cell responses in colorectal cancer. Its integrated genetic, metabolic, immune, and therapeutic experiments position MPC as a potential checkpoint linking tumor metabolism with immunotherapy response.
-
Mubritinib (TAK 165) Experimental Workflows
2026-09-05
Mubritinib (TAK 165) is most useful as a mechanistic probe of mitochondrial complex I, with distinct concentration strategies for chemotherapy-resistant AML and KSHV-positive primary effusion lymphoma. This workflow-led guide covers dosing, orthogonal readouts, HER2 interpretation, assay troubleshooting, and translational limitations.
-
Calpain Inhibition for Translational Neuroprotection
2026-09-05
MDL 28170 illustrates how selective calpain and cathepsin B inhibition can connect protease biology with synaptic plasticity, neuroprotection, and translational assay design. This thought-leadership perspective interprets recent BDNF/TrkB findings and outlines a rigorous workflow for evaluating calpain-dependent injury mechanisms.
-
Dual-Action Control of p38α Dephosphorylation
2026-09-04
The reference study shows that some kinase inhibitors do more than block p38α catalytic activity: they also reshape its activation loop to accelerate WIP1-mediated dephosphorylation. By combining biochemical assays with X-ray crystallography, the work introduces a conformational strategy for improving kinase-inhibitor potency and specificity while clarifying its current limits for inflammation research.